Filtered By:
Infectious Disease: Tuberculosis
Therapy: Neoadjuvant Therapy

This page shows you your search results in order of date.

Order by Relevance | Date

Total 11 results found since Jan 2013.

Rectal cancer combined with abdominal tuberculosis: A case report
CONCLUSION: We aim to emphasize the importance of preoperative and postoperative pathological examination in diagnosis and treatment.PMID:36387825 | PMC:PMC9649531 | DOI:10.12998/wjcc.v10.i31.11523
Source: Clinical Colorectal Cancer - November 17, 2022 Category: Cancer & Oncology Authors: Pei-Gen Liu Xiang-Fan Chen Pan-Feng Feng Source Type: research

Systemic therapy issues: Immunotherapy in nonmetastatic urothelial cancer
Urol Oncol. 2020 Oct 23:S1078-1439(20)30477-4. doi: 10.1016/j.urolonc.2020.10.004. Online ahead of print.ABSTRACTNon-muscle-invasive bladder cancer is one of the most common malignancies. Patients with intermediate-risk or high-risk disease can be treated with intravesical Bacillus Calmette-Guerin, a vaccine against tuberculosis. However, many of these patients will experience tumor recurrence, despite appropriate treatment. 1 The standard of care in these patients is radical cystectomy (RC) with urinary diversion. 2 Patients diagnosed with muscle-invasive bladder cancer (MIBC) have traditionally faced 2 main treatment opt...
Source: Urologic Oncology - November 10, 2021 Category: Urology & Nephrology Authors: Rosa Nadal Andrea B Apolo Daniel M Girardi Noah M Hahn Joaquim Bellmunt Source Type: research